Cancer centre funding boost to widen UK trials of ‘treatments of the future’

43m of support will extend trials of personalised therapies for children and adults at network of specialised medical centres

Cancer patients will have greater access to clinical trials of personalised therapies after a funding boost for specialised medical centres designed to make new treatments available as soon as possible.

Doctors and scientists at 29 experimental cancer medicine centres (ECMCs) in the UK are to receive 43m in fresh support over the next five years to trial new treatments for children and adults. These include drugs that encourage the immune system to attack tumours or prevent cancer cells from growing.